Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 195 Magnetic Resonance Spectroscopy 148 Biopsy 117 pembrolizumab 91 Carboplatin 85 Cisplatin 77 Nivolumab 71 Cyclophosphamide 69 Paclitaxel 64 Gemcitabine 52 Radiotherapy 48 Bevacizumab 44 durvalumab 41 Dexamethasone 37 Fluorouracil 35 Doxorubicin 35 venetoclax 34 Pemetrexed 33 Capecitabine 33 olaparib 32 Rituximab 31 Oxaliplatin 31 Injections 31 atezolizumab 30 Etoposide 29 fludarabine 28 Radiation 28 Prednisone 28 Lenalidomide 27 Docetaxel 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Imlunestrant × 30 days × Clear all

NCT07287098 2026-05-22

preEMBER

Eli Lilly and Company

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡